ArticleNeuro-oncology2024

Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide.

Hong Sheng Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.